|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
4/4/2012 8:23:16 AM
Bio-Rad Laboratories Inc. (BIO), a maker of medical screening and research equipment, rose the most in more than three years on speculation the family-run company may be open to a sale after the death of its founder. Bio-Rad jumped 11 percent to $114.25 in New York, its biggest percentage gain since November 2008. It has a market value of about $3.2 billion. Chairman David Schwartz, who founded Bio-Rad in 1952, died April 1 at age 88, the Hercules, California-based company said in a statement. Schwartz was considered by investors to be opposed to selling the company, Junaid Husain, an analyst at Dougherty & Co. in Minneapolis, said by telephone.
|
|
|
|
|
|
|
|
|
|
|